Impact of delayed time from diagnosis to treatment on the stage of hepatocellular carcinoma
Bing Quan a , b , Wen-Tao Yan a , b , Wan Yee Lau a , c , Meng-Chao Wu a , Tian Yang a , ∗
a Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China
b Department of Clinical Medicine, Second Military Medical University, Shanghai 200433, China
c Faculty of Medicine, the Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China
∗ Corresponding author.
E-mail address: yangtianehbh@smmu.edu.cn (T. Yang).
Abstract：We read with interest of the article by Dr. Lim et al. [1] . The authors concluded that a delay of ≥3 months from diagnosis to treatment in patients with Barcelona clinic liver cancer ( BCLC) 0- A st age hepatocellular carcinoma (HCC) does not affect long-term outcomes after curative resection compared with those with a delay of < 3 months. Undoubtedly, this is a challenging viewpoint, which is contrary to traditional concept – the sooner the tumor removal, the better the oncologic prognosis. Herein, we would like to raise the following comments:
引用本文:
. [J]. Hepatobiliary Pancreat Dis Int, 2019, 18(1): 100-100.
Quan B, Yan WT, Lau WY, Wu MC, Yang T. Impact of delayed time from diagnosis to treatment on the stage of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int, 2019, 18(1): 100-100.
2019, Vol. 18 
